BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Stem cell
,
Neocentromeres
,
Lipopolysaccharide
,
rs6983267
,
PBX1
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TLR 2
Summary
General Info
Curated Studies
Most Correlated Studies
Melanoma or endothelial cell lines stimulated with TLR agonists
Gastric cancer cells treated with Toll-like receptor(TLR) ligand Pam3Cys-Ser-(Lys)4 and FSL-1
Peritoneal macrophages from wildtype mice injected with TLR ligands and from ATF7 knockout mice
Dendritic cells and monocytes treated with different vaccines and TLR ligands
Respiratory epithelial cells treated with synthetic TLR ligands ODN2395 and/or Pam2CSK4
Explore Curated Studies Results
Literature
Most Relevant Literature
Gardnerella vaginalis induces matrix metalloproteinases in the cervicovaginal epithelium through TLR…
Crosstalk of Highly Purified Microglia and Astrocytes in the Frame of Toll-like Receptor (TLR)2/1 Ac…
Polyene Phosphatidylcholine Interacting with TLR-2 Prevents the Synovial Inflammation via Inactivati…
Characterization of a Cutibacterium acnes Camp Factor 1-Related Peptide as a New TLR-2 Modulator in …
TLR-2 agonist Pam3CSK4 has no therapeutic effect on visceral leishmaniasis in BALB/c mice and may en…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome
The Role of TLR-4 Polymorphisms in Children With Urinary Track Infections
Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients
Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ